Annual SGA
$117.93 M
+$16.93 M+16.76%
December 31, 2023
Summary
- As of February 12, 2025, PHAT annual SGA is $117.93 million, with the most recent change of +$16.93 million (+16.76%) on December 31, 2023.
- During the last 3 years, PHAT annual SGA has risen by +$90.41 million (+328.56%).
- PHAT annual SGA is now at all-time high.
Performance
PHAT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$76.10 M
+$227.00 K+0.30%
September 30, 2024
Summary
- As of February 12, 2025, PHAT quarterly SGA is $76.10 million, with the most recent change of +$227.00 thousand (+0.30%) on September 30, 2024.
- Over the past year, PHAT quarterly SGA has increased by +$227.00 thousand (+0.30%).
- PHAT quarterly SGA is now at all-time high.
Performance
PHAT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$4.23 B
-$339.44 M-8.72%
September 30, 2024
Summary
- As of February 12, 2025, PHAT TTM SGA is -$4.23 billion, with the most recent change of -$339.44 million (-8.72%) on September 30, 2024.
- Over the past year, PHAT TTM SGA has dropped by -$4.45 billion (-2038.74%).
- PHAT TTM SGA is now -328453.18% below its all-time high of -$1.29 million.
Performance
PHAT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PHAT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.8% | +0.3% | -2038.7% |
| 3 y3 years | +328.6% | +147.9% | -4289.9% |
| 5 y5 years | +9686.6% | +147.9% | -4289.9% |
PHAT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +88.0% | at high | +309.2% | -122.7% | at low |
| 5 y | 5-year | at high | +1598.3% | at high | +2446.0% | -737.8% | at low |
| alltime | all time | at high | +9686.6% | at high | >+9999.0% | <-9999.0% | at low |
Phathom Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $76.10 M(+0.3%) | $270.98 M(+24.1%) |
| Jun 2024 | - | $75.87 M(+22.4%) | $218.27 M(+35.3%) |
| Mar 2024 | - | $62.01 M(+8.8%) | $161.34 M(+36.8%) |
| Dec 2023 | $117.93 M(+16.8%) | $57.00 M(+143.6%) | $117.93 M(+28.7%) |
| Sep 2023 | - | $23.40 M(+23.5%) | $91.63 M(-0.1%) |
| Jun 2023 | - | $18.94 M(+1.8%) | $91.74 M(-7.7%) |
| Mar 2023 | - | $18.60 M(-39.4%) | $99.35 M(-1.6%) |
| Dec 2022 | $101.00 M(+61.0%) | $30.70 M(+30.6%) | $101.00 M(+12.5%) |
| Sep 2022 | - | $23.51 M(-11.4%) | $89.79 M(+8.4%) |
| Jun 2022 | - | $26.55 M(+31.1%) | $82.81 M(+18.3%) |
| Mar 2022 | - | $20.25 M(+3.9%) | $69.98 M(+11.5%) |
| Dec 2021 | $62.74 M | $19.49 M(+17.9%) | $62.74 M(+16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $16.53 M(+20.5%) | $54.04 M(+21.2%) |
| Jun 2021 | - | $13.72 M(+5.5%) | $44.57 M(+23.8%) |
| Mar 2021 | - | $13.00 M(+20.6%) | $36.01 M(+30.9%) |
| Dec 2020 | $27.52 M(+296.3%) | $10.79 M(+52.8%) | $27.52 M(+39.5%) |
| Sep 2020 | - | $7.06 M(+36.8%) | $19.72 M(+36.3%) |
| Jun 2020 | - | $5.16 M(+14.5%) | $14.47 M(+35.8%) |
| Mar 2020 | - | $4.51 M(+50.9%) | $10.66 M(+53.5%) |
| Dec 2019 | $6.94 M(+476.3%) | $2.99 M(+64.9%) | $6.94 M(+58.1%) |
| Sep 2019 | - | $1.81 M(+34.8%) | $4.39 M(+54.6%) |
| Jun 2019 | - | $1.34 M(+68.8%) | $2.84 M(+89.9%) |
| Mar 2019 | - | $797.00 K(+82.4%) | $1.50 M(+114.0%) |
| Dec 2018 | $1.21 M | $437.00 K(+66.8%) | $699.00 K(+166.8%) |
| Sep 2018 | - | $262.00 K | $262.00 K |
FAQ
- What is Phathom Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals annual SGA year-on-year change?
- What is Phathom Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals quarterly SGA year-on-year change?
- What is Phathom Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals TTM SGA year-on-year change?
What is Phathom Pharmaceuticals annual SGA?
The current annual SGA of PHAT is $117.93 M
What is the all time high annual SGA for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high annual SGA is $117.93 M
What is Phathom Pharmaceuticals annual SGA year-on-year change?
Over the past year, PHAT annual SGA has changed by +$16.93 M (+16.76%)
What is Phathom Pharmaceuticals quarterly SGA?
The current quarterly SGA of PHAT is $76.10 M
What is the all time high quarterly SGA for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high quarterly SGA is $76.10 M
What is Phathom Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, PHAT quarterly SGA has changed by +$227.00 K (+0.30%)
What is Phathom Pharmaceuticals TTM SGA?
The current TTM SGA of PHAT is -$4.23 B
What is the all time high TTM SGA for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high TTM SGA is -$1.29 M
What is Phathom Pharmaceuticals TTM SGA year-on-year change?
Over the past year, PHAT TTM SGA has changed by -$4.45 B (-2038.74%)